TS (TS 106) Antibody sc-33679 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemTS (TS 106) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-33679
Antibody TypePrimary Antibodies
NCBI Gene AliasesTS, DKCD, TMS, Ts, HST422
Quantity200 µg/ml
CloneTS 106
ApplicationsWB, IP, IF, IHC(P), FCM
Reactivitymouse, rat, human
FormatPurified
ClonalityMonoclonal
Hostmouse
Conjugate/TagUnconjugated
NCBI Full Gene Namethymidylate synthase, thymidylate synthetase
TargetThymidylate Synthase
IsotypeIgG1

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Urushiol V Suppresses Cell Proliferation and Enhances Antitumor Activity of 5-FU in Human Colon Cancer Cells by Downregulating FoxM1Biomolecules & therapeuticsMay 1, 2022Jeong JH, Ryu JH.#2535, #5831, #5536, #2972 #9402, Cell Signaling Technology, Danvers, MA, USA), p21, TS (sc-10736, sc-33679, Santa Cruz Biotechnology, Santa Cruz, CA, USA), and β-actin (A2066, Sigma Aldrich, St. Louis, MO, USA). Statistical

(2) Cytosolic localization and in vitro assembly of human de novo thymidylate synthesis complexThe FEBS journalMarch 1, 2022Spizzichino S, Boi D, Boumis G, Lucchi R, Liberati FR, Capelli D, Montanari R, Pochetti G, Piacentini R, Parisi G, et al.rabbit anti‐TYMS (MBS126074; Mybiosource, San Diego, CA, USA) indicated as TYMSR; mouse anti‐TYMS (sc‐33679; Santa Cruz Biotechnology, Inc.) indicated as TYMSM; mouse anti‐PCNA Alexa Fluor® 488‐conjugated antibody

(3) Anti-Tumor Effects of a Penetratin Peptide Targeting Transcription of E2F-1, 2 and 3a Is Enhanced When Used in Combination with Pemetrexed or CisplatinCancersFebruary 26, 2021Rather GM, Anyanwu M, Minko T, Garbuzenko O, Szekely Z, Bertino JR.and TK was checked by Western blot analysis using a standard protocol. Anti-E2F-1(sc-251), anti-TS(sc-33679), anti-TK(sc-56967), anti-vinculin (sc-73614), and secondary antibody were from Santa Cruz Biotechnologies,

(4) Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer CellsPharmacologyJanuary 1, 2020Ko JC, Chen JC, Yen TC, Chen TY, Ma PF, Lin YC, Cheng HH, Taso YC, Lin YW.

(5) Deciphering the potential value of 5-fluorouracil metabolic enzymes in predicting prognosis and treatment response of colorectal cancer patientsThe International journal of biological markersMay 1, 2018Gajjar KK, Vora HH, Kobawala TP, Trivedi TI, Ghosh NR.

(6) Metformin-induced alterations in nucleotide metabolism cause 5-fluorouracil resistance but gemcitabine susceptibility in oesophageal squamous cell carcinomaJournal of cellular biochemistryJanuary 1, 2018Mynhardt C, Damelin LH, Jivan R, Peres J, Prince S, Veale RB, Mavri-Damelin D.

(7) Salinomycin acts through reducing AKT-dependent thymidylate synthase expression to enhance erlotinib-induced cytotoxicity in human lung cancer cellsExperimental cell researchAugust 1, 2017Tung CL, Chen JC, Wu CH, Peng YS, Chen WC, Zheng HY, Jian YJ, Wei CL, Cheng YT, Lin YW.

(8) MicroRNA-330 inhibited cell proliferation and enhanced chemosensitivity to 5-fluorouracil in colorectal cancer by directly targeting thymidylate synthaseOncology lettersMay 1, 2017Xu W, Jiang H, Zhang F, Gao J, Hou J.Inc.). The primary antibodies used in the present study were mouse anti-human monoclonal TYMS (cat. no. sc-33679) and mouse anti-human GADPH (cat. no. sc-59540) (both 1:1,000 dilution; both Santa Cruz Biotechnology, Inc

(9) Relevance of dihydropyrimidine-dehydrogenase and thymidylate-synthase in patients with pancreatic neuroendocrine neoplasms treated with 5-FU-based chemotherapyPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]January 1, 2017Krug S, Boch M, Nimphius W, Gress TM, Michl P, Rinke A.

(10) Evaluating the Prognostic Value of ERCC1 and Thymidylate Synthase Expression and the Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma Non-Small-Cell Lung CancerInternational journal of medical sciencesJanuary 1, 2017Lin CS, Liu TC, Lai JC, Yang SF, Tsao TC.performed to detect ERCC1 and TS expression by using monoclonal ERCC1 and TS antibodies (SC-17809 and SC-33679, respectively, Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), respectively. The protocol of IHC

(11) Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expressionBiochemical pharmacologyDecember 15, 2016Ko JC, Zheng HY, Chen WC, Peng YS, Wu CH, Wei CL, Chen JC, Lin YW.

(12) Astaxanthin enhances pemetrexed-induced cytotoxicity by downregulation of thymidylate synthase expression in human lung cancer cellsRegulatory toxicology and pharmacology : RTPNovember 1, 2016Liao KS, Wei CL, Chen JC, Zheng HY, Chen WC, Wu CH, Wang TJ, Peng YS, Chang PY, Lin YW.

(13) B7-H3 increases thymidylate synthase expression via the PI3k-Akt pathwayTumour biology : the journal of the International Society for Oncodevelopmental Biology and MedicineJuly 1, 2016Jiang B, Liu F, Liu Z, Zhang T, Hua D.

(14) miR-193a-3p is a potential tumor suppressor in malignant pleural mesotheliomaOncotargetSeptember 15, 2015Williams M, Kirschner MB, Cheng YY, Hanh J, Weiss J, Mugridge N, Wright CM, Linton A, Kao SC, Edelman JJ, et al.

(15) CES2, ABCG2, TS and Topo-I primary and synchronous metastasis expression and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI regimenInternational journal of molecular sciencesSeptember 5, 2014Silvestris N, Simone G, Partipilo G, Scarpi E, Lorusso V, Brunetti AE, Maiello E, Paradiso A, Mangia A.

(16) Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cellsOncology reportsJanuary 1, 2014Gu W, Liu L, Fang FF, Huang F, Cheng BB, Li B.

(17) Monitoring drug target engagement in cells and tissues using the cellular thermal shift assayScience (New York, N.Y.)July 5, 2013Martinez Molina D, Jafari R, Ignatushchenko M, Seki T, Larsson EA, Dan C, Sreekumar L, Cao Y, Nordlund P.

(18) Right-sided rhabdoid colorectal tumors might be related to the serrated pathwayDiagnostic pathologyFebruary 20, 2013Pancione M, Remo A, Sabatino L, Zanella C, Votino C, Fucci A, Di Blasi A, Lepore G, Daniele B, Fenizia F, et al.using the following antibodies: VEGFR1 (sc-65442) and VEGFR2 (sc-101560); thymidylate synthase (TS) (sc-33679); APC (sc-896); (Santa Cruz Biotechnology, Santa Cruz, Ca, USA); HDACI (ab19845), HDACII (ab61216),

(19) Expression and pharmacological inhibition of thymidylate synthase and Src kinase in nonsmall cell lung cancerInternational journal of cancerApril 15, 2012Ceppi P, Rapa I, Lo Iacono M, Righi L, Giorcelli J, Pautasso M, Billè A, Ardissone F, Papotti M, Scagliotti GV.

(20) Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cellsThe Journal of pharmacology and experimental therapeuticsJuly 1, 2011Ko JC, Tsai MS, Chiu YF, Weng SH, Kuo YH, Lin YW.

Be the First to Write a Review!

TS (TS 106) Antibody

TS (TS 106) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (24)

Reviews

TS (TS 106) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map